Stay updated on Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears near the top of the page.
    Difference
    0.7%
    Check dated 2026-10-25T13:49:00.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T14:15:54.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The website footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T14:04:11.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The revision entry now shows v3.7.0 in the history, replacing the previous v3.6.6, indicating an update to the page's revision records.
    Difference
    0.1%
    Check dated 2026-09-20T19:51:39.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The study record history now lists a new revision v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-30T08:32:08.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.6.5 has been added to the page history, replacing the previous v3.6.4. This signals a minor software/version update to the ClinicalTrials.gov interface rather than changes to trial data or content.
    Difference
    0.2%
    Check dated 2026-08-08T23:21:34.000Z thumbnail image

Stay in the know with updates to Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.